Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
130M
-
Number of holders
-
68
-
Total 13F shares, excl. options
-
48M
-
Shares change
-
-2.96M
-
Total reported value, excl. options
-
$42M
-
Value change
-
-$2.67M
-
Put/Call ratio
-
1.92
-
Number of buys
-
32
-
Number of sells
-
-27
-
Price
-
$0.88
Significant Holders of PROKIDNEY CORP. - Ordinary Shares (PROK) as of Q1 2025
79 filings reported holding PROK - PROKIDNEY CORP. - Ordinary Shares as of Q1 2025.
PROKIDNEY CORP. - Ordinary Shares (PROK) has 68 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48M shares
of 130M outstanding shares and own 36.97% of the company stock.
Largest 10 shareholders include SUVRETTA CAPITAL MANAGEMENT, LLC (12.3M shares), MORGAN STANLEY (10.3M shares), BlackRock, Inc. (6.76M shares), VANGUARD GROUP INC (5.21M shares), GEODE CAPITAL MANAGEMENT, LLC (2.32M shares), Bleichroeder LP (2M shares), STATE STREET CORP (1.73M shares), Brown University (1M shares), NORTHERN TRUST CORP (907K shares), and Hennion & Walsh Asset Management, Inc. (844K shares).
This table shows the top 68 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.